Despite showing a linear association with PFS, the signature did not reach statistical significance in patients treated in the STORM trial.
← all excerpts
Unraveling the complexity of drug resistance mechanisms to SINE, T cell-engaging therapies and CELMoDs in multiple myeloma: a comprehensive review.
1
—
—